2-189863774-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000534.5(PMS1):c.1888C>T(p.Arg630Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000854 in 1,604,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000534.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PMS1 | NM_000534.5 | c.1888C>T | p.Arg630Ter | stop_gained | 10/13 | ENST00000441310.7 | NP_000525.1 | |
LOC105373796 | XR_001739151.2 | n.98+757G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PMS1 | ENST00000441310.7 | c.1888C>T | p.Arg630Ter | stop_gained | 10/13 | 1 | NM_000534.5 | ENSP00000406490 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151936Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000148 AC: 37AN: 249896Hom.: 0 AF XY: 0.000148 AC XY: 20AN XY: 135376
GnomAD4 exome AF: 0.0000861 AC: 125AN: 1452064Hom.: 0 Cov.: 28 AF XY: 0.0000844 AC XY: 61AN XY: 723100
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151936Hom.: 0 Cov.: 30 AF XY: 0.0000809 AC XY: 6AN XY: 74202
ClinVar
Submissions by phenotype
PMS1-related breast cancer Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 28, 2023 | - - |
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PMS1 p.Arg630* variant was identified in the literature in a female patient with uveal melanoma, congenital bilateral nevus of Ota and ocular surface melanosis (Toomey_2019_PMID:31367589). The variant was identified in dbSNP (ID: rs139932286) and ClinVar (submitted by ITMI, classification not provided). The variant was identified in control databases in 38 of 266820 chromosomes at a frequency of 0.0001424 (Genome Aggregation Database March 6, 2019, v2.1.1, non-cancer). The variant was observed in the following populations: Ashkenazi Jewish in 22 of 9822 chromosomes (freq: 0.00224), Latino in 5 of 35036 chromosomes (freq: 0.000143), South Asian in 3 of 30488 chromosomes (freq: 0.000098) and European (non-Finnish) in 8 of 117296 chromosomes (freq: 0.000068), but was not observed in the African, East Asian, European (Finnish), or Other populations. The c.1888C>T variant leads to a premature stop codon at position 630 which is predicted to lead to a truncated or absent protein and loss of function. However, the role of loss of function PMS1 variants in disease is not currently well established. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at